SUBSCRIBE
SUBSCRIBE
News   Drug Development

MediGene’s Phase III Drug Effective In Genital Warts

October 19, 2005 | 
1 min read

MediGene AG completed its second Phase III trial of Polyphenon E, a treatment for genital warts, getting significant clinical effects compared to placebo, as well as good tolerability.

Clinical research Phase III Europe
MORE ON THIS TOPIC
Pictured: Boehringer Ingelheim sign on a building/
Schizophrenia
Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS
January 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Businessman jump careful on cracked or broken graph. Job opportunity and career. concept of under pressure. risk, financial, and tax
Pipeline
New Safety Signals Force Keros to Fully Terminate Mid-Stage PAH Study
January 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Business
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
January 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Pictured: A sign on a J.P. Morgan building in Hong Kong/iStock, danielvfung
Pipeline
JPM25 Day One: Pfizer, BioNTech, Moderna and More Present Pipeline Updates
January 14, 2025
 · 
3 min read
 · 
Dan Samorodnitsky